VC Funding for Bay State Biotechs Dropped 36 Percent
A major source of funding for Massachusetts life science companies dropped sharply in 2022, but still exceeds pre-pandemic investment levels.
by Steve Adams | Jan 12, 2023
A major source of funding for Massachusetts life science companies dropped sharply in 2022, but still exceeds pre-pandemic investment levels.
by Steve Adams | Sep 12, 2021
Dozens of commercial developers have shifted their focus to lab projects amid the boom, others see overlooked opportunities in the industrial market’s R&D and flex space.
by Steve Adams | Jun 8, 2021
A projected 18 million square feet of lab space is scheduled for completion in Greater Boston in 2023, potentially tempering the skyrocketing rent increases being driven by the life science industry’s space demand.
by Steve Adams | May 5, 2021
Institutional investors rank Boston as the second-most desirable U.S. market for investment in 2021 and the only non-Sunbelt metro in the top four.
by Banker & Tradesman | Nov 29, 2020
There remains plenty of capital for real estate ventures and funds are being raised, but investors are selective on where that capital is being placed.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Special offer for new subscribers –
try B&T online for just $9.99 for your first month!
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.